01451nas a2200373   4500000000100000008004100001260000900042653001500051653001000066653000900076653002800085653002900113653001900142653001000161653001200171653003000183653001100213653001100224653002300235653002500258653000900283653001600292653002200308100001600330700001800346700001300364700001700377700001300394245004500407300001100452490000800463520059200471022001401063       1991                            d  c199110aAdolescent10aAdult10aAged10aAntibodies, Antinuclear10aAntigen-Antibody Complex10aAutoantibodies10aChild10aDapsone10aDrug Therapy, Combination10aFemale10aHumans10aLeprostatic Agents10aLeprosy, lepromatous10aMale10aMiddle Aged10aRheumatoid Factor1 aGraninger W1 aHollenstein U1 aDudeck U1 aKremsner P G1 aSaylan T00a[Autoantibodies in lepromatous leprosy].  a268-700 v1033 a<p>84 Turkish patients with lepromatous and borderline lepromatous leprosy were investigated with regard to the presence of antibodies to a variety of tissue constituents and immunoglobulins. Thirty Turkish-born volunteers and two groups of patients with systemic lupus erythematosus and primary biliary cirrhosis respectively served as controls. No increased incidence of autoantibodies to smooth muscle cells, nuclei, mitochondria, striated muscle, thyroid microsomes and thyroglobulin was detected. A high incidence of rheumatoid factor and circulating immune complexes was found.</p>  a0043-5325